Cardiovascular Critical Care I
Supraventricular Tachyarrhythmias
Type
Rhythm
P-wave
Attributes
Atrial Rate
(beats/min)
Description
Multifocal atrial
tachycardias
(MATs)
Irregular
> 3 different
types of
distinct P
waves
100–130
Can be misdiagnosed as AF
Commonly associated with respiratory disease, HF,
critical illness
May be exacerbated by electrolyte abnormalities or
toxicity with digoxin or theophylline
Ventricular Arrhythmias
Type
Description
Premature ventricular
complexes (PVCs)
Results from an ectopic ventricular focus conduction that can be identified by the
lack of a preceding P wave. Commonly benign or asymptomatic but may be of
concern if present in patterns or in patients with advanced heart disease
Bigeminy: Every other beat is a PVC
Trigeminy: Every third beat is a PVC
Couplets: Patterns of two consecutive PVCs
Triplets: Patterns of three consecutive PVCs
Ventricular Arrhythmias
Type
Description
Ventricular
tachycardia (VT)
Potentially lethal wide QRS complex tachycardia characterized according to
morphology and duration; can degenerate into ventricular fibrillation (VF) or
asystole
Monomorphic VT: When every QRS complex appears the same and the rate is
regular (100–200 beats/min); commonly caused by reentry circuit related to
myocardial scar or fibrosis
Polymorphic: When the QRS complexes continually vary in shape and rate; most
commonly caused by myocardial ischemia, but other causes include multiple
ectopic foci or torsades de pointes from QT prolongation.
Non-sustained VT: Self-terminating episodes lasting for < 30 s
Sustained VT: If VT persists for more than 30 s, produces severe symptoms,
including syncope, or requires termination by administration of an
antiarrhythmic drug or direct cardioversion/defibrillation
VT storm: ≥ 3 episodes of sustained VT in a 24-h period
Ventricular fibrillation
(VF)
Life-threatening arrhythmia with a chaotic ECG with no discernible QRS,
representing rapid disorganized conduction with no resultant coordinated
ventricular contractions
aOther arrhythmias beyond the scope of this review include sick sinus syndrome (tachy-brady syndrome).
Management of tachyarrhythmias with a pulse includes the following strategies:
Stabilization of patient: See Figure 9
Atrial tachyarrhythmias
| (a) | Heart rate control typically with class II agents, class IV agents, and/or digoxin (see |
|---|
Appendix A)
2002;324:1264-7; BMJ 2002;324:1201-4; Circulation 2012;125:381-9; Heart Fail Rev 2014;19:285-93; J Am Coll
Cardiol 2018;72:1677-749) (continued)